Association between the γ-aminobutyric acid A3 receptor gene and multiple sclerosis

Archives of Neurology

Volumn 55, Issue 4, 1998, Pages 513-516

  Gade Andavolu, Radhika ^a   MacMurray, James P ^b   Blake, Hezekiah ^a   Muhleman, Donn ^a   Tourtellotte, Wallace ^c   Comings, David E ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^b LOMA LINDA UNIVERSITY   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; RECEPTOR SUBUNIT;

ALLELE; ARTICLE; DOPAMINE METABOLISM; GENE FREQUENCY; GENETIC LINKAGE; GENETIC POLYMORPHISM; HUMAN; HUMAN TISSUE; MULTIPLE SCLEROSIS; NUCLEOTIDE REPEAT; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROLACTIN RELEASE;

ALLELES; CHI-SQUARE DISTRIBUTION; CYTOKINES; FEMALE; GAMMA-AMINOBUTYRIC ACID; GLUTAMATE DECARBOXYLASE; HUMANS; LINKAGE (GENETICS); LYMPHOCYTES; MALE; MULTIPLE SCLEROSIS; PROLACTIN; RECEPTORS, GABA-A; RISK FACTORS; TWIN STUDIES; X CHROMOSOME;

EID: 0031918145     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.55.4.513     Document Type: Article

References (36)

1. Haegert DG, Marrosu MG. Genetic susceptibility to multiple sclerosis. Ann Neurol. 1994;36(suppl 2):S204-S210.
2. Manyam NV, Katz L, Hare TA, Gerber JC. Levels of gamma-aminobutyric acid in cerebrospinal fluid in various neurologic disorders. Arch Neurol. 1980;37:352-355.
3. Manyam NV, Trebley RD. Free and conjugated GABA in human cerebrospinal fluid: effect of degenerative neurologic diseases and isoniazid. Brain Res. 1984;307: 217-223.
4. Bass B, Weinshenker B, Rice GP, et al. Tizanidine versus baclofen in the treatment of spasticity in patients with multiple sclerosis. Can J Neurol Sci. 1998;15:19.
5. Stein EC, Schiffer RB, Hall WJ, Young N. Multiple sclerosis and the workplace: report of an industry based cluster. Neurology. 1987;37:1672-1677.
6. Sanders VJ, Felisan S, Waddell A, Touretellotte W. Detection of herpes viridae in postmortem multiple sclerosis brain tissue and controls by polymerase chain reaction. J Neurovirol. 1996;2:249-258.
7. Simontov R, Oster-Granite ML, Herndon RM, Snyder SH. Gamma aminobutyric acid (GABA) receptor binding selectively depelted by viral induced granule cell loss in hamster cerebellum. Brain Res. 1996;5:365-371.
8. Morfin R, Caurchay G. Pregnenolone and dehydroepiandosterone as precursors of native 7-hydroxylated metabolites with increase in the immune response in mice. J Steroid Biochem Mol Biol. 1994;50:91-100.
9. Hao JX, Xu XJ, Yu YX, Seiger A, Wiesenfeld-Hallin Z. Baclofen reverses the hypersensitivity of dorsal horn wide dynamic range neurons to mechanical stimulation after transient spinal cord ischemia: implication for a tonic GABAergic inhibitory control of myelinated fibre input. J Neurophysiol. 1992;68:392-396.
10. 3-subunits with serotonergic and GABAergic neurons. Neuroscience. 1993;54:881-892.
11. Comings DE, MacMurray JP, Gade R, Muhleman D, Peters WR. Genetic variants of the human obesity gene: association with psychiatric symptoms and body mass index in young women, and interaction with the dopamine D2 receptor gene. Mol Psychiatry. 1996;1:325-335.
12. Comings DE, Muhleman D, Gade R, et al. Cannabinoid receptor gene (CNR1): association with IV drug use. Mol Psychiatry. 1997;2:161-168.
13. Gade R, Muhlemann D, MacMurray J, Comings DE. Correlation of length of VNTR alleles at the X-linked MAOA gene and phenotypic effect in Tourette syndrome and drug abuse. Mol Psychiatry. 1998;3:50-60.
14. Comings DE. Polygenic inheritance and micro/minisatellites. Mol Psychiatry. 1998; 3:21-31.
15. 3-subunit gene. Nucleic Acids Res. 1992;19:4016.
16. Ebers GC. Genetics and multiple sclerosis: an overview. Ann Neurol. 1994;36 (suppl):S12-S14.
17. Kuokkanen S, Sundvall M, Terwilliger JD, et al. A putative vulnerability locus to multiple sclerosis maps to 5p14-p12 in a region syntenic to the murine locus Eae2. Nat Genet. 1996;13:477-480.
18. Ebers GC, Kukay K, Bulman DE, et al. A full genome search in multiple sclerosis. Nat Genet. 1996;13:472-476.
19. Haines JL, Ter-Minassian M, Bazyk A, et al. A complete genomic screen for multiple sclerosis underscores a role for the major histocompatibility complex: The Multiple Sclerosis Genetics Group. Nat Genet. 1996;13:469-471.
20. Sawcer S, Jones HB, Feakes R, et al. A genome screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22. Nat Genet. 1996;13: 464-468.
21. Erlander MG, Tobin AJ. The structural and functional heterogeneity of glutamic acid decarboxylase: a review. Neurochem Res. 1991;16:215-216.
22. Hou J, Said C, Franchi D, Dockstader P, Chatterjee NK. Antibodies to glutamic acid decarboxylase and P2-C peptides in sera from coxsackievirus B4-infected mice and IDDM patients. Diabetes. 1994;43:1260-1266.
23. Richter W, Mertens T, Schoel B, et al. Sequence homology of the diabetes associated autoantigen glutamate decarboxylase with coxsackie b4-2c protein and heat shock protein 60 mediates no molecular mimicry of autoantibodies. J Exp Med. 1994;180:721-726.
24. Ellis TM, Atkinson MA. The clinical significance of an autoimmune response against glutamic acid decarboxylase. Nat Med. 1996;2:148-153.
25. Wapelhorst B, Bell GI, Risch N, Spielman RS, Concannon P. Linkage and association studies in insulin-dependent diabetes with a new dinucleotide repeat polymorphism at the GAD65 locus. Autoimmunity. 1995;21:127-130.
26. Patterson PH. Cytokines in Alzheimer's disease and multiple sclerosis. Curr Opin Neurobiol. 1995;5:642-646.
27. Miller LG, Fahey JM. Interleukin-1 modulates GABAergic and glutamatergic function in brain. Ann N Y Acad Sci. 1994;739:292-298.
28. Blanchi M, Ferrario P, Zonta N, Panerai AE. Effects of interleukin-1 beta and interleukin-2 on amino acids levels in mouse cortex and hippocampus. Neuroreport. 1995;6:1689-1692.
29. Price ML, Hoffer BJ, Granholm AC. Effects of GDNF on fetal septal forebrain transplants in oculo. Exp Neurol. 1996;141:181-189.
30. Yokoyama M, Morrison RS, Black IB, Dreyfus CF. Septal neuron cholinergic and GABAergic functions: differential regulation by basic fibroblast growth factor and epidermal growth factor. Brain Res Dev Brain Res. 1994;78:201-209.
31. Rocca P, Ferrero P, Gualerzi A, et al. Peripheral-type benzodiazepine receptors in anxiety disorders. Acta Psychiatr Scand. 1991;84:537-544.
32. Ferrarese C, Appollonio I, Frigo M, et al. Decreased density of benzodiazepine receptors in lymphocytes of anxious patients: reversal after chronic diazepam treatment. Acta Psychiatr Scand. 1990;82:169-173.
33. Alexander BE, Roller E, Klotz U. Characterization of peripheral-type benzodiazepine binding sites on human lymphocytes and lymphoma cell lines and their role in cell growth. Biochem Pharmacol. 1992;44:269-274.
34. Moingeon P, Dessaux JJ, Fellous R, et al. Benzodiazepine receptors on human blood platelets. Life Sci. 1984;35:2003-2009.
35. Lucas K, Hohlfeld R. Differential aspects of cytokines in the immunopathology of multiple sclerosis. Neurology. 1995;6(suppl):S4-S5.
36. Duvilanski BH, Zambruno C, Lasaga M, Pisera D, Seilicovich A. Role of nitric oxide/ cyclic GMP pathway in the inhibitory effect of GAGA and dopamine on prolactin release. J Neuroendocrinol. 1996;8:909-913.